Partner Investment Management LP Has Decreased By $1.42 Million Its Clovis Oncology (CLVS) Stake; Last Week FCB Financial Holdings, Inc. (FCB) Analysts

December 6, 2017 - By Ellis Scott

Among 10 analysts covering FCB Financial Holdings (NYSE:FCB), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. FCB Financial Holdings had 16 analyst reports since July 22, 2015 according to SRatingsIntel. Hovde Group maintained the stock with “Outperform” rating in Monday, August 22 report. The stock has “Buy” rating by Gabelli on Thursday, January 7. The stock of FCB Financial Holdings, Inc. (NYSE:FCB) earned “Hold” rating by Keefe Bruyette & Woods on Tuesday, October 3. The rating was maintained by Deutsche Bank with “Buy” on Friday, November 6. Deutsche Bank maintained it with “Buy” rating and $44 target in Friday, September 23 report. The rating was maintained by RBC Capital Markets on Thursday, September 7 with “Buy”. The firm earned “Neutral” rating on Wednesday, January 11 by UBS. Raymond James initiated the shares of FCB in report on Wednesday, November 30 with “Mkt Perform” rating. The stock of FCB Financial Holdings, Inc. (NYSE:FCB) has “Market Perform” rating given on Monday, November 14 by Hovde Group. The firm has “Buy” rating by RBC Capital Markets given on Wednesday, October 25. See FCB Financial Holdings, Inc. (NYSE:FCB) latest ratings:

25/10/2017 Broker: RBC Capital Markets Rating: Buy New Target: $54.0 Maintain
03/10/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $51.0 Maintain
07/09/2017 Broker: RBC Capital Markets Rating: Buy New Target: $54.0 Maintain
26/07/2017 Broker: RBC Capital Markets Rating: Buy New Target: $54.0000 Maintain
17/07/2017 Broker: RBC Capital Markets Rating: Outperform New Target: $56 Initiates Coverage On

Partner Investment Management Lp decreased Clovis Oncology Inc (CLVS) stake by 69.76% reported in 2017Q2 SEC filing. Partner Investment Management Lp sold 15,233 shares as Clovis Oncology Inc (CLVS)’s stock declined 20.61%. The Partner Investment Management Lp holds 6,604 shares with $618,000 value, down from 21,837 last quarter. Clovis Oncology Inc now has $2.89 billion valuation. The stock increased 2.22% or $1.28 during the last trading session, reaching $58.97. About 973,477 shares traded. Clovis Oncology, Inc. (NASDAQ:CLVS) has risen 282.71% since December 6, 2016 and is uptrending. It has outperformed by 266.01% the S&P500.

Analysts await Clovis Oncology, Inc. (NASDAQ:CLVS) to report earnings on February, 28. They expect $-1.27 EPS, up 30.60% or $0.56 from last year’s $-1.83 per share. After $-1.24 actual EPS reported by Clovis Oncology, Inc. for the previous quarter, Wall Street now forecasts 2.42% negative EPS growth.

Since June 15, 2017, it had 0 insider purchases, and 1 insider sale for $185,460 activity. IVERS-READ GILLIAN C also sold $185,460 worth of Clovis Oncology, Inc. (NASDAQ:CLVS) on Thursday, June 15.

Partner Investment Management Lp increased Godaddy Inc stake by 9,279 shares to 46,566 valued at $1.98 million in 2017Q2. It also upped Anthem Inc (NYSE:ANTM) stake by 1,897 shares and now owns 12,534 shares. Molina Healthcare Inc (NYSE:MOH) was raised too.

Among 20 analysts covering Clovis Oncology (NASDAQ:CLVS), 14 have Buy rating, 0 Sell and 6 Hold. Therefore 70% are positive. Clovis Oncology had 54 analyst reports since September 10, 2015 according to SRatingsIntel. The rating was upgraded by PiperJaffray to “Overweight” on Thursday, January 26. The firm has “Neutral” rating by Mizuho given on Monday, January 25. The firm has “Buy” rating by Janney Capital given on Tuesday, June 20. The firm has “Outperform” rating given on Wednesday, September 21 by Credit Suisse. Stifel Nicolaus maintained Clovis Oncology, Inc. (NASDAQ:CLVS) on Friday, February 26 with “Buy” rating. The stock of Clovis Oncology, Inc. (NASDAQ:CLVS) has “Hold” rating given on Monday, July 31 by Oppenheimer. The stock has “Neutral” rating by Goldman Sachs on Tuesday, November 17. The company was maintained on Wednesday, November 15 by Leerink Swann. WallachBeth Capital downgraded the shares of CLVS in report on Tuesday, November 17 to “Hold” rating. The firm has “Outperform” rating given on Thursday, January 21 by Credit Suisse.

Investors sentiment decreased to 1.81 in 2017 Q2. Its down 0.66, from 2.47 in 2017Q1. It dived, as 33 investors sold CLVS shares while 56 reduced holdings. 74 funds opened positions while 87 raised stakes. 46.46 million shares or 12.58% more from 41.27 million shares in 2017Q1 were reported. Cubist Systematic Strategies Limited Com reported 0% stake. Alliancebernstein Limited Partnership stated it has 0.07% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Hanseatic Mngmt invested in 0.65% or 13,693 shares. Omega Advisors owns 50,000 shares. Marshall Wace Limited Liability Partnership has invested 0.03% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). Jennison Associate holds 0.12% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS) for 1.19 million shares. Acadian Asset Mngmt Lc has invested 0% in Clovis Oncology, Inc. (NASDAQ:CLVS). Sabby Mngmt Ltd Company owns 7,065 shares or 0.04% of their US portfolio. Bain Cap Pub Equity Llc owns 0.79% invested in Clovis Oncology, Inc. (NASDAQ:CLVS) for 140,558 shares. Tiaa Cref Limited Liability Corporation invested 0.02% of its portfolio in Clovis Oncology, Inc. (NASDAQ:CLVS). 28,000 were reported by State Of Wisconsin Board. Amer Group invested in 24,416 shares. 42,309 were reported by Kennedy Mgmt. Moreover, Insight Rech Mgmt Incorporated has 0.48% invested in Clovis Oncology, Inc. (NASDAQ:CLVS). Hamilton Lane Advsr Ltd Liability Corporation holds 0.55% or 10,724 shares.

The stock decreased 0.10% or $0.05 during the last trading session, reaching $51.15. About 128,530 shares traded. FCB Financial Holdings, Inc. (NYSE:FCB) has risen 30.63% since December 6, 2016 and is uptrending. It has outperformed by 13.93% the S&P500.

Investors sentiment increased to 1.52 in 2017 Q2. Its up 0.26, from 1.26 in 2017Q1. It improved, as 16 investors sold FCB Financial Holdings, Inc. shares while 46 reduced holdings. 29 funds opened positions while 65 raised stakes. 40.28 million shares or 2.98% more from 39.11 million shares in 2017Q1 were reported. Alpine Woods Cap Ltd Liability Co owns 11,500 shares or 0.03% of their US portfolio. Creative Planning reported 0% stake. M&T Bancorporation invested in 8,221 shares or 0% of the stock. Morgan Stanley invested 0% in FCB Financial Holdings, Inc. (NYSE:FCB). Moreover, Numeric Investors Limited Liability Com has 0.12% invested in FCB Financial Holdings, Inc. (NYSE:FCB). Regions Fincl Corporation owns 15,197 shares. Symphony Asset Ltd Company has invested 0.09% of its portfolio in FCB Financial Holdings, Inc. (NYSE:FCB). Sg Americas Lc accumulated 6,277 shares or 0% of the stock. California State Teachers Retirement Sys invested in 0.01% or 62,433 shares. Westfield Cap Mgmt L P owns 675,440 shares or 0.27% of their US portfolio. Quantbot Technologies Lp accumulated 385 shares. Basswood Capital Mgmt Ltd has 0.13% invested in FCB Financial Holdings, Inc. (NYSE:FCB). Tiaa Cref Mngmt Lc invested 0% of its portfolio in FCB Financial Holdings, Inc. (NYSE:FCB). Hennessy Incorporated has 0.26% invested in FCB Financial Holdings, Inc. (NYSE:FCB) for 180,000 shares. Geode Mngmt Ltd reported 327,959 shares stake.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Ellis Scott




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: